Next Generation Non-Viral Gene Therapies with Cove Therapeutics CEO, Niren Shah
Our guest in this episode is Cove Therapeutics CEO, Niren Shah, who discusses the pitfalls of current viral vector based gene therapies and shares how Cove's next generation non-viral gene delivery platform overcomes many of the challenges of viral vectors.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.